Effects of Prostaglandin E1 analogue, Misoprostol, on the development of adjuvant arthritis in rats

Simple item page
dc.contributor.authorRainsford, K.
dc.contributor.authorWhitehouse, M.
dc.contributor.authorVernon-Roberts, B.
dc.date.issued1995
dc.description.abstractProstaglandins (PG) E , E and the PGE analogue, misoprostol, have been shown to inhibit T-cell functions and the production by activated monocytes or macrophages of interleukin-1, indicating that these PGs may have potential anti-arthritic activity by suppressing T-cell and monocyte activity. In view of this the potential anti-arthritic effects of the long half-life PG, misoprostol (MPL), were examined in adjuvant arthritic rats under prophylactic and therapeutic treatment regimes. Transcutaneous or subcutaneous MPL given at 200 Μg/kg/day but not at 50 or 5 Μg/kg/day when given 0 to +5 or 0 to + 14 days post-induction inhibited the development of the disease whereas the orally administered drug was without effects. MPL given transcutaneously with oral indomethacin (1 or 2 mg/kg/day) on days +17 to + 30 post-induction produced greater anti-inflammatory effects than with this NSAID alone. MPL given orally in combination with this NSAID did not enhance the anti-inflammatory effects of the latter. MPL 200 Μg/kg given transcutaneously exhibited anti-ulcer activity against indomethacin (30 mg/kg p.o.), naproxen (10 mg/kg i.p.) or piroxicam (5 mg/kg i.p.) induced gastric damage in arthritic rats and this was comparable with that from 100 Μg/kg MPL given orally. These results show that MPL has both unique anti-arthritic effects only when given transcutaneously or parenterally as well as anti-ulcer activity.
dc.description.statementofresponsibilityK. D. Rainsford, M. W. Whitehouse and B. Vernon-Roberts
dc.identifier.citationInflammopharmacology: experimental and clinical studies, 1995; 3(1):49-63
dc.identifier.doi10.1007/BF02659110
dc.identifier.issn0925-4692
dc.identifier.issn1568-5608
dc.identifier.urihttp://hdl.handle.net/2440/5643
dc.language.isoen
dc.publisherKluwer Academic Publishers
dc.source.urihttps://doi.org/10.1007/bf02659110
dc.subjectProstaglandin analogues
dc.subjectArthritis
dc.subjectNon-steroidal anti-inflammatory drugs
dc.subjectMisoprostol
dc.subjectInflammation
dc.titleEffects of Prostaglandin E1 analogue, Misoprostol, on the development of adjuvant arthritis in rats
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Pathology publications